Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="de Galocsy, C" or (type exact bookEditor and editor="de Galocsy, C")

Add to list
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon : a Belgian experience

R Bielen, C Moreno, Hans Van Vlierberghe (UGent) , S Bourgeois, J-P Mulkay, T Vanwolleghem, W Verlinden, C Brixco, J Decaestecker, C de Galocsy, et al.

(2017) JOURNAL OF VIRAL HEPATITIS. 24(11). p.976-981
Add to list
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

A Arain, S Bourgeois, C de Galocsy, J Henrion, P Deltenre, F d'Heygere, C George, B Bastens, L Van Overbeke, R Verrando, et al.

(2016) JOURNAL OF MEDICAL VIROLOGY. 88(1). p.94-99
Add to list
- Conference Paper
- C1
GLEM/LOK report on staging procedures in digestive tumours: results, comments and recommendations.

Marc Peeters (UGent) , C DE GALOCSY, E VANDERSTRAETEN, J DEBONGNIE, R FIASSE and André Elewaut (UGent)

(2007) Acta Gastro-Enterologica Belgica. 70.
Add to list
- Miscellaneous
Hepatitis C: Screening, treatment and prevention practical guidelines

P MICHIELSEN, R BRENARD, N BOURGEOIS, C DE GALOCSY, J DELWAIDE, J HENRION, Y HORSMANS, F NEVENS, H REYNAERT, G ROBAEYS, et al.

(2003) ACTA GASTRO-ENTEROLOGICA BELGICA. 66(1). p.15-19
Add to list
- Journal Article
- A1
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial

Hans Van Vlierberghe (UGent) , Geert Leroux-Roels (UGent) , M ADLER, N BOURGEOIS, F NEVENS, Y HORSMANS, J BROUWER, Isabelle Colle (UGent) , J DELWAIDE, R BRENARD, et al.

(2003) JOURNAL OF VIRAL HEPATITIS. 10(6). p.460-466

Academic Bibliography

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon : a Belgian experience

Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs

GLEM/LOK report on staging procedures in digestive tumours: results, comments and recommendations.

Hepatitis C: Screening, treatment and prevention practical guidelines

Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial

Contents

Support

Contact